New Zealand markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
104.23-0.59 (-0.56%)
At close: 04:00PM EDT
104.26 +0.03 (+0.03%)
After hours: 07:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
40,326,000
40,109,000
43,653,000
43,075,000
34,608,000
Cost of revenue
18,107,000
17,975,000
19,142,000
18,537,000
15,003,000
Gross profit
22,219,000
22,134,000
24,511,000
24,538,000
19,605,000
Operating expenses
Research development
2,771,000
2,741,000
2,888,000
2,742,000
2,420,000
Selling general and administrative
11,146,000
10,949,000
11,248,000
11,324,000
9,696,000
Total operating expenses
15,864,000
15,656,000
16,149,000
16,113,000
14,248,000
Operating income or loss
6,355,000
6,478,000
8,362,000
8,425,000
5,357,000
Interest expense
625,000
637,000
558,000
533,000
546,000
Total other income/expenses net
444,000
438,000
319,000
276,000
111,000
Income before tax
6,538,000
6,664,000
8,306,000
8,211,000
4,968,000
Income tax expense
908,000
941,000
1,373,000
1,140,000
497,000
Income from continuing operations
5,630,000
5,723,000
6,933,000
7,071,000
4,471,000
Net income
5,630,000
5,723,000
6,933,000
7,071,000
4,495,000
Net income available to common shareholders
5,630,000
5,723,000
6,933,000
7,071,000
4,495,000
Basic EPS
2.95
3.30
3.99
4.01
2.54
Diluted EPS
2.94
3.26
3.91
3.94
2.50
Basic average shares
1,741,035
1,734,076
1,737,795
1,764,082
1,771,230
Diluted average shares
1,750,670
1,749,000
1,764,000
1,789,000
1,786,000